Search research articles
Contact Us
Filters
Showing results (371-380 of 617) with videos related to
Page
of 62
Sort By:
Metabolism: Clinical and Experimental
|
March 27, 2012
Fatty acid flux and oxidation are increased by rimonabant in obese women
Katharine Backhouse, Ivana Sarac, Fariba Shojaee-Moradie, et al.
Biology of Sex Differences
|
May 8, 2019
Sex differences in negative affect and postoperative pain in patients undergoing total knee arthroplasty
Meghna Nandi, Kristin L Schreiber, Marc O Martel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group
Robert Gray, Judith Manola, Scott Saxman, et al.
British Journal of Haematology
|
August 3, 2006
Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response?
John Gerecitano, Andre Goy, John Wright, et al.
BMJ Open
|
June 30, 2022
Vulnerabilities in child well-being among primary school children: a cross-sectional study in Bradford, UK
Kate E Pickett, Mildred Ajebon, Bo Hou, et al.
Cancer Medicine
|
January 24, 2013
Biomarker-driven trial in metastatic pancreas cancer: feasibility in a multicenter study of saracatinib, an oral Src inhibitor, in previously treated pancreatic cancer
John Arcaroli, Kevin Quackenbush, Arvind Dasari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2005
A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer
Helen Mackay, David Hedley, Pierre Major, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2007
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study
Terzah M Horton, Debananda Pati, Sharon E Plon, et al.
Archives of Pathology & Laboratory Medicine
|
December 1, 2018
Data Set for the Reporting of Malignant Odontogenic Tumors: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting
Pieter J Slootweg, Edward W Odell, Daniel Baumhoer, et al.
Wellcome Open Research
|
June 14, 2024
COVID-19 vaccine hesitancy in an ethnically diverse community: descriptive findings from the Born in Bradford study
Josie Dickerson, Bridget Lockyer, Rachael H Moss, et al.
Page
of 62
Search research articles
Search
Showing results (371-380 of 617) with videos related to
Sort By:
Page
of 62
Metabolism: Clinical and Experimental
|
March 27, 2012
Fatty acid flux and oxidation are increased by rimonabant in obese women
Katharine Backhouse, Ivana Sarac, Fariba Shojaee-Moradie, et al.
Biology of Sex Differences
|
May 8, 2019
Sex differences in negative affect and postoperative pain in patients undergoing total knee arthroplasty
Meghna Nandi, Kristin L Schreiber, Marc O Martel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group
Robert Gray, Judith Manola, Scott Saxman, et al.
British Journal of Haematology
|
August 3, 2006
Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response?
John Gerecitano, Andre Goy, John Wright, et al.
BMJ Open
|
June 30, 2022
Vulnerabilities in child well-being among primary school children: a cross-sectional study in Bradford, UK
Kate E Pickett, Mildred Ajebon, Bo Hou, et al.
Cancer Medicine
|
January 24, 2013
Biomarker-driven trial in metastatic pancreas cancer: feasibility in a multicenter study of saracatinib, an oral Src inhibitor, in previously treated pancreatic cancer
John Arcaroli, Kevin Quackenbush, Arvind Dasari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2005
A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer
Helen Mackay, David Hedley, Pierre Major, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2007
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study
Terzah M Horton, Debananda Pati, Sharon E Plon, et al.
Archives of Pathology & Laboratory Medicine
|
December 1, 2018
Data Set for the Reporting of Malignant Odontogenic Tumors: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting
Pieter J Slootweg, Edward W Odell, Daniel Baumhoer, et al.
Wellcome Open Research
|
June 14, 2024
COVID-19 vaccine hesitancy in an ethnically diverse community: descriptive findings from the Born in Bradford study
Josie Dickerson, Bridget Lockyer, Rachael H Moss, et al.
Page
of 62